PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

First performance standards published to measure the effectiveness of lifestyle medicine treatments

The measures are significant because adopting standards to document remission and long term-progress can facilitate the broader integration of lifestyle medicine into healthcare

2024-03-28
(Press-News.org) An expert panel has published the first performance measures to identify remission and evaluate the effectiveness of lifestyle medicine treatments, which will allow more objective comparisons between lifestyle behavior interventions and other non-lifestyle treatments.

The performance measures are significant because, as interest in the field of lifestyle medicine has grown, it became clear that the lack of standards to document remission or long-term progress following lifestyle medicine treatment was a barrier to the widespread integration of the practice into healthcare, said American College of Lifestyle Medicine Founding President John Kelly, MD, MPH, DipABLM, FACLM, lead author of the paper published in the American Journal of Lifestyle Medicine.

Lifestyle medicine is a medical specialty that uses therapeutic lifestyle interventions as a primary modality to treat chronic conditions including, but not limited to, cardiovascular diseases, type 2 diabetes, and obesity.  Lifestyle medicine-certified clinicians are trained to apply evidence-based, whole-person, prescriptive lifestyle change to treat and, when used intensively, often reverse such conditions. Applying the six pillars of lifestyle medicine—a whole-food, plant-predominant eating pattern, physical activity, restorative sleep, stress management, positive social connections, and avoidance of risky substances—also provides effective prevention for these conditions.

“Many clinical practice guidelines call it important to address lifestyle behaviors in the treatment of chronic disease but, without measurable performance standards, it was not possible to effectively evaluate progress or long-term outcomes for patients following lifestyle medicine interventions,” Dr. Kelly said. “These new performance measures defined by the expert panel will help clinicians adopt evidence-based lifestyle medicine by equipping them with the standards they need to measure the success of those treatments.”

The expert panel focused on 10 diseases, conditions or risk factors and proposes using outcomes collected after three months of treatment with lifestyle medicine. The conditions included cardiac function, cardiac risk factors, cardiac medications and procedures, patient-centered cardiac health, hypertension, type 2 diabetes and prediabetes, metabolic syndrome, inflammatory conditions, inflammatory condition patient-centered measures, and chronic kidney disease. Patient-centered measures are metrics relevant to quality of life, such as quality of life or pain assessments.

For each disease, specific measurements were chosen to demonstrate if lifestyle medicine should be considered effective. For example, to measure the effectiveness of lifestyle medicine treatment for hypertension, the panel identified systolic and diastolic blood pressure three months after starting lifestyle interventions to address a poor diet and lack of exercise. The panel also considered important the use of medication or procedures with known effects on hypertension. Ultimately, 32 performance measures reached consensus.

The process for developing the performance measures made clear the need for a set of standards showing the effectiveness of lifestyle medicine, said Micaela Karlsen, PhD, MSPH, senior director of research for the American College of Lifestyle Medicine and last author of the paper.

“You would not expect surgery, a procedure or medication to be prescribed if no evidence existed that it worked,” Dr. Karlsen said. “Our hope is these standards will be widely adopted by health practitioners.”

As the field of lifestyle medicine continues to grow, the measurements will play an important role. Future work should use these measurements in data collection in the electronic medical record (EMR) system to standardize evaluation of lifestyle medicine treatment effectiveness and performance, the panel recommended.  

ABOUT ACLM

The American College of Lifestyle Medicine is the nation’s medical professional society advancing lifestyle medicine as the foundation for a redesigned, value-based and equitable healthcare delivery system, leading to whole-person health. ACLM educates, equips, empowers and supports its members through quality, evidence-based education, certification and research to identify and eradicate the root cause of chronic disease, with a clinical outcome goal of health restoration as opposed to disease management

END


ELSE PRESS RELEASES FROM THIS DATE:

To keep volunteers, connect them

2024-03-28
At a time when America needs volunteers more than ever, to tackle social problems from homelessness to disaster recovery, fewer people have been volunteering. The number of volunteers for nonprofit and community-based organizations declined recently for the first time in decades, from 30% of the population in 2019 to 23% in 2021. That’s according to AmeriCorps and the U.S Census Bureau, which have tracked rates of volunteerism since 2002. New research from Yifan Yu, assistant professor of ...

Suppressing boredom at work hurts future productivity, study shows

2024-03-28
Boredom is more common at work than in any other setting, studies show, and employees are bored at work for more than 10 hours per week on average. Even astronauts and police officers get bored on the job. No occupation is immune. Boredom serves an important purpose — it signals the need to stop an action and find an alternative project. But boredom becomes problematic when it’s ignored. New research from the University of Notre Dame shows that trying to stifle boredom prolongs its effects and that alternating boring and meaningful tasks helps to prevent the effects of one boring task from ...

Older brain cells linger unexpectedly before their death

Older brain cells linger unexpectedly before their death
2024-03-28
For oligodendrocytes—the central nervous system cells critical for brain function—age may not bring wisdom, but it does come with the power to cling to life for much, much longer than scientists knew. That's according to a new study featured on the March 27 cover of the Journal of Neuroscience. Mature oligodendrocytes took a shocking 45 days to die following a fatal trauma that killed younger cells within the expected 24 hours, Dartmouth researchers report. The findings suggest there's a new pathway for efforts to reverse or prevent the damage that aging and diseases such as multiple sclerosis cause to these important cells. In the brain, ...

Clear shift in arterial diseases in diabetes

Clear shift in arterial diseases in diabetes
2024-03-28
There has been a redistribution in the risk of arterial disease in type 1 and 2 diabetes. The risks of heart attack and stroke have decreased significantly, while complications in more peripheral vessels have increased in relative importance, according to studies at the University of Gothenburg. It is well known that type 1 and 2 diabetes increase the risk of heart attack and stroke. Previous research has also identified the clearest cardiometabolic risk factors in this context, such as obesity, lipid disorders, and high blood pressure. How diabetes and cardiometabolic risk factors affect blood ...

Celebrating half a century of pioneering excellence: EBMT marks its 50th anniversary

2024-03-28
Barcelona, 27 March 2024 – The EBMT proudly commemorates its 50th anniversary, marking five decades of transformative advancements in the field of hematopoietic cell transplantation (HCT) and cellular therapy. More than 5,000 healthcare professionals will gather from the 14th to the 17th of April, 2024, at the Scottish Event Campus in Glasgow for this special edition and they will immerse themselves in cutting-edge scientific content, network with their peers from across the globe, and be part of a community that is driving innovation and change. In 1974, a small group ...

Ancient DNA reveals the appearance of a 6th century Chinese emperor

Ancient DNA reveals the appearance of a 6th century Chinese emperor
2024-03-28
What did an ancient Chinese emperor from 1,500 years ago look like? A team of researchers reconstructed the face of Chinese Emperor Wu of Northern Zhou using DNA extracted from his remains. The study, published March 28 in the journal Current Biology, suggests the emperor’s death at the age of 36 might be linked to a stroke. It also sheds light on the origin and migration patterns of a nomadic empire that once ruled parts of northeastern Asia. Emperor Wu was a ruler of the Northern Zhou dynasty in ancient China. Under his reign from AD 560 to AD 578, Emperor Wu built a strong military and unified the northern part ...

DNA study IDs descendants of George Washington from unmarked remains, findings to aid service member IDs going back to World War II

2024-03-28
New DNA sequencing technologies have identified the historical remains of George Washington’s grandnephews, Samuel Walter Washington and George Steptoe Washington Jr., and their mother, Lucy Payne Washington, from unmarked, fragmentary bones left at the Harewood family cemetery in Charles Town, West Virginia, in the mid-1800s. In addition to enabling the remains in question to be reunited and reburied if desired, the researchers plan to apply the validated DNA analysis techniques to their ongoing efforts to identify the remains of service members lost around the world in past conflicts going back to World War II. The findings appear March 28 in the journal iScience. “The ...

Familial Alzheimer’s disease transferred via bone marrow transplant in mice

Familial Alzheimer’s disease transferred via bone marrow transplant in mice
2024-03-28
Familial Alzheimer’s disease can be transferred via bone marrow transplant, researchers show March 28 in the journal Stem Cell Reports. When the team transplanted bone marrow stem cells from mice carrying a hereditary version of Alzheimer’s disease into normal lab mice, the recipients developed Alzheimer’s disease—and at an accelerated rate. The study highlights the role of amyloid that originates outside of the brain in the development of Alzheimer’s disease, which changes the paradigm of Alzheimer’s from being a disease ...

Perspectives of oncologists on the ethical implications of using AI for cancer care

2024-03-28
About The Study: In this survey study of 204 oncologists, few reported that patients needed to understand artificial intelligence (AI) models, but most agreed that patients should consent to their use, and many tasked patients with choosing between physician- and AI-recommended treatment regimens. These findings suggest that the implementation of AI in oncology must include rigorous assessments of its effect on care decisions as well as decisional responsibility when problems related to AI use arise.  Authors: Gregory A. Abel, M.D., M.P.H., of the Dana-Farber Cancer Institute in Boston, is the corresponding author.   To ...

Industry payments to US physicians by specialty and product type

2024-03-28
About The Study: From 2013 to 2022, U.S. physicians received $12.1 billion from industry. More than half of physicians received at least one payment. Payments varied widely between specialties and between physicians within the same specialty. A small number of physicians received the largest amounts, often exceeding $1 million, while the median physician received much less, typically less than a hundred dollars.   Authors: Andrew J. Foy, M.D., of the Penn State Milton S. Hershey ...

LAST 30 PRESS RELEASES:

Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV-related disease, but huge variations between countries in coverage

Negativity about vaccines surged on Twitter after COVID-19 jabs become available

Global measles cases almost double in a year

Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen

Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds

Experts developing immune-enhancing therapies to target tuberculosis

Making transfusion-transmitted malaria in Europe a thing of the past

Experts developing way to harness Nobel Prize winning CRISPR technology to deal with antimicrobial resistance (AMR)

CRISPR is promising to tackle antimicrobial resistance, but remember bacteria can fight back

Ancient Maya blessed their ballcourts

Curran named Fellow of SAE, ASME

Computer scientists unveil novel attacks on cybersecurity

Florida International University graduate student selected for inaugural IDEA2 public policy fellowship

Gene linked to epilepsy, autism decoded in new study

OHSU study finds big jump in addiction treatment at community health clinics

Location, location, location

Getting dynamic information from static snapshots

Food insecurity is significant among inhabitants of the region affected by the Belo Monte dam in Brazil

The Society of Thoracic Surgeons launches new valve surgery risk calculators

Component of keto diet plus immunotherapy may reduce prostate cancer

New circuit boards can be repeatedly recycled

Blood test finds knee osteoarthritis up to eight years before it appears on x-rays

April research news from the Ecological Society of America

Antimicrobial resistance crisis: “Antibiotics are not magic bullets”

Florida dolphin found with highly pathogenic avian flu: Report

Barcodes expand range of high-resolution sensor

DOE Under Secretary for Science and Innovation visits Jefferson Lab

Research expo highlights student and faculty creativity

Imaging technique shows new details of peptide structures

MD Anderson and RUSH unveil RUSH MD Anderson Cancer Center

[Press-News.org] First performance standards published to measure the effectiveness of lifestyle medicine treatments
The measures are significant because adopting standards to document remission and long term-progress can facilitate the broader integration of lifestyle medicine into healthcare